Development of an inducible protein expression system based on the protozoan host Leishmania tarentolae
- PMID: 15939291
- DOI: 10.1016/j.pep.2005.03.004
Development of an inducible protein expression system based on the protozoan host Leishmania tarentolae
Abstract
Production of functional eukaryotic proteins in recombinant form is a bottle-neck in various post-genomic applications and in life science in general. At least partially this is due to the problems associated with the use of endogenous RNA polymerase II for high-level transcription of heterologous genes in eukaryotic expression systems. To circumvent these problems we developed a new inducible protein expression system based on the protozoan host Leishmania tarentolae (Trypanosomatidae). We have created a strain of L. tarentolae constitutively co-expressing T7 RNA polymerase and tetracycline repressor. This strain could be stably transformed with the heterologous target gene under control of the T7 promoter/TET operator assembly, which can initiate transcription upon addition of tetracycline to the culture medium. Using this system, we demonstrated that enhanced green fluorescent protein (EGFP) could be overexpressed to a level of ca. 1% of total cellular protein. The developed system was tested for its ability to inducibly co-express multiple genes. Using two copies of the egfp gene integrated at two different genomic sites, we could obtain expression levels reaching 4% of total cellular protein. Further possible improvements and applications of the developed system are discussed.
Similar articles
-
Artificial linear episome-based protein expression system for protozoon Leishmania tarentolae.Mol Biochem Parasitol. 2011 Apr;176(2):69-79. doi: 10.1016/j.molbiopara.2010.12.002. Epub 2010 Dec 15. Mol Biochem Parasitol. 2011. PMID: 21167214
-
Isotopic labeling of recombinant proteins expressed in the protozoan host Leishmania tarentolae.Protein Expr Purif. 2006 Aug;48(2):167-72. doi: 10.1016/j.pep.2006.04.006. Epub 2006 Apr 25. Protein Expr Purif. 2006. PMID: 16740394
-
Recombinant protein production in the eukaryotic protozoan parasite Leishmania tarentolae: a review.Methods Mol Biol. 2012;824:307-15. doi: 10.1007/978-1-61779-433-9_15. Methods Mol Biol. 2012. PMID: 22160905 Review.
-
A T7 RNA polymerase-dependent gene expression system for Bacillus megaterium.Appl Microbiol Biotechnol. 2009 Apr;82(6):1195-203. doi: 10.1007/s00253-009-1952-5. Epub 2009 Mar 24. Appl Microbiol Biotechnol. 2009. PMID: 19308404
-
Transient and inducible expression of vaccinia/T7 recombinant viruses.Methods Mol Biol. 2004;269:41-50. doi: 10.1385/1-59259-789-0:041. Methods Mol Biol. 2004. PMID: 15114006 Review.
Cited by
-
CRISPR/Cas9 in Leishmania mexicana: A case study of LmxBTN1.PLoS One. 2018 Feb 13;13(2):e0192723. doi: 10.1371/journal.pone.0192723. eCollection 2018. PLoS One. 2018. PMID: 29438445 Free PMC article.
-
Recombinant pharmaceuticals from microbial cells: a 2015 update.Microb Cell Fact. 2016 Feb 9;15:33. doi: 10.1186/s12934-016-0437-3. Microb Cell Fact. 2016. PMID: 26861699 Free PMC article. Review.
-
U-insertion/deletion RNA editing multiprotein complexes and mitochondrial ribosomes in Leishmania tarentolae are located in antipodal nodes adjacent to the kinetoplast DNA.Mitochondrion. 2015 Nov;25:76-86. doi: 10.1016/j.mito.2015.10.006. Epub 2015 Oct 14. Mitochondrion. 2015. PMID: 26462764 Free PMC article.
-
A putative ATP/GTP binding protein affects Leishmania mexicana growth in insect vectors and vertebrate hosts.PLoS Negl Trop Dis. 2017 Jul 24;11(7):e0005782. doi: 10.1371/journal.pntd.0005782. eCollection 2017 Jul. PLoS Negl Trop Dis. 2017. PMID: 28742133 Free PMC article.
-
Leishmania tarentolae as a platform for the production of vaccines against viral pathogens.NPJ Vaccines. 2024 Nov 6;9(1):212. doi: 10.1038/s41541-024-01005-9. NPJ Vaccines. 2024. PMID: 39505865 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources